New developments in cancer treatment require medication experts—here's how you can become that expert.
Legislation removes FDA involvement when patients seek experimental medications. Here’s what critics and proponents say.
Oral rivaroxaban may be preferable to injections of low-molecular-weight heparins for patients being treated for cancer.
It may depend on where you are and where you are in your career.
Public health officials and activists call for action to reverse the rising U.S. maternal death rate.
Pharmacists should understand what Rh incompatibility during pregnancy is and how it is treated.
High-dose inactivated influenza vaccinations from community pharmacists during 2012-2013 flu season were more effective than standard-dose inactivated flu shots in patients 65 years and older, and helped in the prevention of influenza-associated hospitalizations, according to a comparative effectiveness study published in The Lancet Infectious Diseases.
FDA has approved two new HIV-1 cocktail drugs: elvitegravir (Vitekta, Gilead), an integrase inhibitor and cobicistat (Tybost, Gilead), a protease-inhibitor booster.
FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.